These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34087280)

  • 21. Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.
    Dwivedi AR; Thakur A; Kumar V; Skvortsova I; Kumar V
    Curr Drug Targets; 2020; 21(3):258-278. PubMed ID: 31433755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives.
    Kharkar PS
    J Med Chem; 2020 Dec; 63(24):15279-15307. PubMed ID: 33325699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Products That Target Cancer Stem Cells.
    Moselhy J; Srinivasan S; Ankem MK; Damodaran C
    Anticancer Res; 2015 Nov; 35(11):5773-88. PubMed ID: 26503998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical approaches to targeting drug resistance in cancer stem cells.
    Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
    Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways.
    Abetov D; Mustapova Z; Saliev T; Bulanin D; Batyrbekov K; Gilman CP
    Stem Cell Rev Rep; 2015 Dec; 11(6):909-18. PubMed ID: 26210995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomaterials for targeted drug delivery to cancer stem cells.
    Orza A; Casciano D; Biris A
    Drug Metab Rev; 2014 May; 46(2):191-206. PubMed ID: 24697156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
    Krishnamurthy S; Ke X; Yang YY
    Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy.
    Li H; Yan W; Suo X; Peng H; Yang X; Li Z; Zhang J; Liu D
    Biomaterials; 2019 Apr; 200():1-14. PubMed ID: 30743049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches for targeting cancer stem cells drug resistance.
    Rosa R; D'Amato V; De Placido S; Bianco R
    Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer Stem Cells and Targeting Strategies.
    Barbato L; Bocchetti M; Di Biase A; Regad T
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.